Melanie Bull

Melanie has worked within the API and ATMP industry for 12 years using aseptic manufacturing techniques to produce sterile and non-sterile products for in-vivo and ex-vivo use. With Oxford Biomedica she is responsible for the manufacturing design and delivery of their new lentiviral vector manufacturing facility for producing the bulk and finished product ATMP’s.